Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 34 | 2022 | 1066 | 4.590 |
Why?
|
Tracheal Neoplasms | 16 | 2021 | 126 | 3.830 |
Why?
|
Thoracic Surgical Procedures | 10 | 2019 | 340 | 2.900 |
Why?
|
Esophagectomy | 18 | 2022 | 458 | 2.190 |
Why?
|
Lung Neoplasms | 35 | 2022 | 12183 | 1.920 |
Why?
|
Thoracic Surgery | 11 | 2019 | 684 | 1.840 |
Why?
|
Tracheal Stenosis | 7 | 2021 | 223 | 1.380 |
Why?
|
Esophageal Neoplasms | 15 | 2021 | 1449 | 1.340 |
Why?
|
Respiratory Paralysis | 2 | 2016 | 32 | 1.240 |
Why?
|
Societies, Medical | 14 | 2019 | 3776 | 1.220 |
Why?
|
Recurrent Laryngeal Nerve | 2 | 2016 | 144 | 1.130 |
Why?
|
Thoracic Surgery, Video-Assisted | 8 | 2022 | 290 | 1.120 |
Why?
|
Diaphragm | 2 | 2016 | 352 | 1.110 |
Why?
|
Thymectomy | 2 | 2015 | 199 | 1.040 |
Why?
|
Thoracic Wall | 3 | 2019 | 193 | 1.020 |
Why?
|
Mediastinal Neoplasms | 4 | 2018 | 442 | 0.930 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2020 | 267 | 0.920 |
Why?
|
Laryngeal Neoplasms | 5 | 2010 | 490 | 0.890 |
Why?
|
Postoperative Complications | 27 | 2021 | 15053 | 0.880 |
Why?
|
Tracheal Diseases | 5 | 2007 | 111 | 0.850 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 9 | 2022 | 4865 | 0.850 |
Why?
|
Databases, Factual | 17 | 2021 | 7763 | 0.800 |
Why?
|
Respiration | 2 | 2016 | 1665 | 0.770 |
Why?
|
Biomedical Research | 4 | 2019 | 3266 | 0.750 |
Why?
|
Tracheostomy | 2 | 2021 | 400 | 0.740 |
Why?
|
Laryngectomy | 4 | 2010 | 234 | 0.710 |
Why?
|
Intubation, Intratracheal | 6 | 2021 | 1312 | 0.710 |
Why?
|
Carcinoma, Adenoid Cystic | 6 | 2019 | 263 | 0.620 |
Why?
|
Trachea | 8 | 2012 | 1076 | 0.620 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 416 | 0.590 |
Why?
|
Bronchial Neoplasms | 5 | 2006 | 109 | 0.580 |
Why?
|
Neoplasm Staging | 16 | 2022 | 11126 | 0.540 |
Why?
|
Tracheoesophageal Fistula | 3 | 2018 | 109 | 0.540 |
Why?
|
Pleural Neoplasms | 4 | 2020 | 600 | 0.520 |
Why?
|
Anemia, Hemolytic | 1 | 2014 | 161 | 0.490 |
Why?
|
Esophagus | 8 | 2012 | 1019 | 0.480 |
Why?
|
Pulmonary Veno-Occlusive Disease | 2 | 2013 | 64 | 0.470 |
Why?
|
Anastomosis, Surgical | 10 | 2021 | 958 | 0.470 |
Why?
|
Registries | 4 | 2017 | 7989 | 0.460 |
Why?
|
Reconstructive Surgical Procedures | 3 | 2021 | 2137 | 0.460 |
Why?
|
Retrospective Studies | 49 | 2022 | 71483 | 0.450 |
Why?
|
Myasthenia Gravis | 1 | 2014 | 190 | 0.440 |
Why?
|
Angiography | 1 | 2018 | 1675 | 0.440 |
Why?
|
Neoadjuvant Therapy | 7 | 2019 | 2561 | 0.430 |
Why?
|
Bronchial Diseases | 3 | 2005 | 145 | 0.420 |
Why?
|
Muscle, Skeletal | 4 | 2020 | 4969 | 0.410 |
Why?
|
Esophagitis | 3 | 2003 | 139 | 0.410 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1899 | 0.400 |
Why?
|
Airway Obstruction | 5 | 2010 | 651 | 0.390 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2019 | 3876 | 0.390 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 622 | 0.390 |
Why?
|
Humans | 132 | 2022 | 708843 | 0.380 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 667 | 0.370 |
Why?
|
Deglutition Disorders | 5 | 2017 | 566 | 0.370 |
Why?
|
Esophageal Diseases | 4 | 2008 | 166 | 0.350 |
Why?
|
Treatment Outcome | 35 | 2022 | 61932 | 0.330 |
Why?
|
Respiratory Tract Fistula | 1 | 2007 | 23 | 0.330 |
Why?
|
Reoperation | 7 | 2021 | 4159 | 0.320 |
Why?
|
Granular Cell Tumor | 1 | 2007 | 52 | 0.320 |
Why?
|
Esophageal Perforation | 3 | 2022 | 69 | 0.320 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 84 | 0.320 |
Why?
|
Patient Selection | 4 | 2019 | 4306 | 0.310 |
Why?
|
Male | 90 | 2021 | 349524 | 0.310 |
Why?
|
Thyroidectomy | 2 | 2010 | 892 | 0.310 |
Why?
|
Aged | 66 | 2022 | 161488 | 0.310 |
Why?
|
Middle Aged | 73 | 2022 | 213752 | 0.310 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2022 | 429 | 0.310 |
Why?
|
Survival Rate | 17 | 2021 | 13202 | 0.300 |
Why?
|
Quality Improvement | 7 | 2019 | 3733 | 0.300 |
Why?
|
Sarcopenia | 2 | 2021 | 304 | 0.300 |
Why?
|
Female | 87 | 2021 | 375205 | 0.290 |
Why?
|
Bronchoscopy | 5 | 2021 | 842 | 0.290 |
Why?
|
Bronchi | 3 | 2019 | 845 | 0.280 |
Why?
|
Gastric Emptying | 2 | 2021 | 229 | 0.280 |
Why?
|
Esophageal Achalasia | 1 | 2006 | 88 | 0.280 |
Why?
|
Thyroid Neoplasms | 2 | 2010 | 2219 | 0.280 |
Why?
|
Advisory Committees | 3 | 2018 | 759 | 0.280 |
Why?
|
Diverticulum | 1 | 2006 | 134 | 0.270 |
Why?
|
Pleura | 2 | 2020 | 231 | 0.270 |
Why?
|
Thoracic Neoplasms | 1 | 2006 | 259 | 0.250 |
Why?
|
Thoracotomy | 5 | 2017 | 361 | 0.250 |
Why?
|
Survival Analysis | 10 | 2021 | 10507 | 0.250 |
Why?
|
Mesothelioma | 1 | 2009 | 774 | 0.240 |
Why?
|
Gastroesophageal Reflux | 3 | 2006 | 701 | 0.230 |
Why?
|
Lymph Node Excision | 3 | 2022 | 1179 | 0.230 |
Why?
|
Bronchial Fistula | 2 | 2018 | 77 | 0.230 |
Why?
|
Pulmonary Emphysema | 3 | 1996 | 673 | 0.220 |
Why?
|
Intussusception | 1 | 2003 | 120 | 0.220 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 507 | 0.220 |
Why?
|
Stents | 4 | 2022 | 3312 | 0.220 |
Why?
|
Esophageal Stenosis | 3 | 2009 | 176 | 0.210 |
Why?
|
Adenocarcinoma | 11 | 2019 | 6338 | 0.210 |
Why?
|
Internship and Residency | 1 | 2021 | 5556 | 0.210 |
Why?
|
Barrett Esophagus | 3 | 2011 | 497 | 0.210 |
Why?
|
Jejunum | 2 | 1993 | 502 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 8877 | 0.200 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2020 | 28 | 0.200 |
Why?
|
Calcinosis | 1 | 2009 | 1435 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 11 | 2022 | 20308 | 0.200 |
Why?
|
Laryngostenosis | 2 | 2010 | 158 | 0.200 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 73 | 0.190 |
Why?
|
Catheter Ablation | 2 | 2013 | 2506 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39038 | 0.190 |
Why?
|
Adult | 45 | 2021 | 211041 | 0.180 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2483 | 0.180 |
Why?
|
Colon | 3 | 2008 | 1762 | 0.180 |
Why?
|
Gastric Outlet Obstruction | 2 | 2011 | 54 | 0.180 |
Why?
|
Pylorus | 2 | 2011 | 91 | 0.180 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2010 | 1829 | 0.180 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1330 | 0.170 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1896 | 0.170 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 207 | 0.170 |
Why?
|
Stomach | 2 | 2021 | 673 | 0.170 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2176 | 0.170 |
Why?
|
Diverticulum, Esophageal | 1 | 2017 | 12 | 0.170 |
Why?
|
Lung Diseases | 2 | 2009 | 1889 | 0.170 |
Why?
|
Thoracoscopy | 2 | 2017 | 176 | 0.170 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 780 | 0.160 |
Why?
|
Preoperative Care | 2 | 2018 | 2357 | 0.160 |
Why?
|
United States | 17 | 2022 | 67165 | 0.160 |
Why?
|
Physician's Role | 1 | 2004 | 982 | 0.150 |
Why?
|
Biopsy | 2 | 2020 | 6766 | 0.150 |
Why?
|
Candidiasis | 1 | 1999 | 367 | 0.150 |
Why?
|
Massachusetts | 4 | 2021 | 8712 | 0.150 |
Why?
|
Forecasting | 2 | 2017 | 2941 | 0.140 |
Why?
|
Catheterization | 3 | 2011 | 1463 | 0.140 |
Why?
|
Neuromuscular Blockade | 1 | 2016 | 147 | 0.140 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 3693 | 0.140 |
Why?
|
Thoracic Diseases | 1 | 2016 | 97 | 0.140 |
Why?
|
Databases as Topic | 1 | 2017 | 480 | 0.140 |
Why?
|
Consensus | 2 | 2021 | 2713 | 0.140 |
Why?
|
Aged, 80 and over | 23 | 2022 | 58184 | 0.130 |
Why?
|
Lung | 6 | 2022 | 9706 | 0.130 |
Why?
|
Combined Modality Therapy | 7 | 2009 | 8896 | 0.130 |
Why?
|
Necrosis | 4 | 2003 | 1646 | 0.130 |
Why?
|
Hospital Mortality | 5 | 2012 | 5095 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1693 | 0.130 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 329 | 0.130 |
Why?
|
Burns, Inhalation | 1 | 1993 | 32 | 0.130 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 31 | 0.130 |
Why?
|
Length of Stay | 4 | 2020 | 6257 | 0.130 |
Why?
|
Muscle Weakness | 1 | 2016 | 403 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1934 | 0.120 |
Why?
|
Body Composition | 2 | 2020 | 2393 | 0.120 |
Why?
|
Dyspnea | 4 | 2012 | 1237 | 0.120 |
Why?
|
Esophagogastric Junction | 2 | 2016 | 297 | 0.120 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2013 | 15 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 5112 | 0.120 |
Why?
|
Forced Expiratory Volume | 5 | 2019 | 1724 | 0.120 |
Why?
|
Incidence | 4 | 2020 | 20320 | 0.120 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 26 | 0.120 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 8024 | 0.120 |
Why?
|
Muscle Strength | 1 | 2016 | 570 | 0.120 |
Why?
|
Amyloidosis | 1 | 2020 | 788 | 0.120 |
Why?
|
Muscular Diseases | 1 | 2016 | 555 | 0.110 |
Why?
|
Esophageal Fistula | 2 | 2003 | 56 | 0.110 |
Why?
|
Risk Factors | 12 | 2021 | 69553 | 0.110 |
Why?
|
Atrial Fibrillation | 2 | 2013 | 4454 | 0.110 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3439 | 0.110 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2019 | 98 | 0.110 |
Why?
|
Hospital Costs | 1 | 2018 | 982 | 0.110 |
Why?
|
Fundoplication | 2 | 2017 | 143 | 0.110 |
Why?
|
Esophagoscopy | 2 | 2011 | 401 | 0.100 |
Why?
|
Silicones | 1 | 2012 | 248 | 0.100 |
Why?
|
Benchmarking | 1 | 2017 | 915 | 0.100 |
Why?
|
Lymph Nodes | 1 | 2022 | 3409 | 0.100 |
Why?
|
Tracheomalacia | 1 | 2010 | 63 | 0.100 |
Why?
|
Computer Simulation | 2 | 2021 | 6048 | 0.100 |
Why?
|
Pleurodesis | 1 | 2010 | 41 | 0.100 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2009 | 91 | 0.090 |
Why?
|
Risk Adjustment | 2 | 2017 | 587 | 0.090 |
Why?
|
Risk Assessment | 8 | 2018 | 23284 | 0.090 |
Why?
|
General Surgery | 1 | 2021 | 1645 | 0.090 |
Why?
|
Cough | 3 | 2012 | 555 | 0.090 |
Why?
|
Research | 1 | 2018 | 2009 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 766 | 0.090 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1121 | 0.090 |
Why?
|
Echocardiography, Transesophageal | 2 | 2021 | 1109 | 0.090 |
Why?
|
Mediastinal Diseases | 1 | 2009 | 95 | 0.090 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 182 | 0.090 |
Why?
|
Hemoptysis | 2 | 2010 | 149 | 0.090 |
Why?
|
Esophagoplasty | 1 | 2008 | 50 | 0.090 |
Why?
|
Pleural Diseases | 1 | 2009 | 131 | 0.090 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1419 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3234 | 0.080 |
Why?
|
Microsatellite Instability | 1 | 2011 | 664 | 0.080 |
Why?
|
Lymphangiosarcoma | 1 | 2006 | 13 | 0.080 |
Why?
|
Sarcoma | 2 | 2011 | 1854 | 0.080 |
Why?
|
Patient Readmission | 1 | 2021 | 2952 | 0.080 |
Why?
|
Medical Audit | 1 | 2008 | 475 | 0.080 |
Why?
|
Osteolysis, Essential | 1 | 2006 | 32 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8638 | 0.080 |
Why?
|
Gastric Fistula | 1 | 2007 | 73 | 0.080 |
Why?
|
Lung Transplantation | 1 | 1996 | 1152 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2009 | 1887 | 0.080 |
Why?
|
Life Tables | 1 | 2006 | 380 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4615 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2274 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 254 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6765 | 0.070 |
Why?
|
Adolescent | 14 | 2019 | 84718 | 0.070 |
Why?
|
Child | 12 | 2019 | 73636 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2015 | 2951 | 0.070 |
Why?
|
Recurrence | 2 | 2009 | 8255 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19423 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4254 | 0.070 |
Why?
|
Respiratory Sounds | 2 | 2010 | 682 | 0.070 |
Why?
|
Hoarseness | 1 | 2005 | 63 | 0.070 |
Why?
|
Time Factors | 8 | 2019 | 41038 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2028 | 0.070 |
Why?
|
Body Mass Index | 2 | 2019 | 12366 | 0.070 |
Why?
|
Laryngoscopy | 1 | 2010 | 712 | 0.070 |
Why?
|
Thymoma | 1 | 2005 | 171 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2017 | 16008 | 0.060 |
Why?
|
Tracheotomy | 1 | 2004 | 168 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 245 | 0.060 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1214 | 0.060 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 215 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2009 | 709 | 0.060 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 618 | 0.060 |
Why?
|
Prognosis | 8 | 2020 | 28919 | 0.060 |
Why?
|
Salivary Gland Neoplasms | 1 | 2006 | 295 | 0.060 |
Why?
|
Chondrosarcoma | 1 | 2005 | 296 | 0.060 |
Why?
|
Prospective Studies | 4 | 2021 | 50597 | 0.060 |
Why?
|
Morbidity | 2 | 2019 | 1690 | 0.060 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 2865 | 0.060 |
Why?
|
Muscle, Smooth | 1 | 2006 | 945 | 0.060 |
Why?
|
Chest Pain | 1 | 2009 | 1100 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1260 | 0.050 |
Why?
|
beta-Galactosidase | 2 | 1999 | 623 | 0.050 |
Why?
|
Device Removal | 1 | 2006 | 656 | 0.050 |
Why?
|
Immunohistochemistry | 6 | 2020 | 11790 | 0.050 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2001 | 25 | 0.050 |
Why?
|
Radiography | 3 | 2009 | 6989 | 0.050 |
Why?
|
Child, Preschool | 6 | 2019 | 41081 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3515 | 0.050 |
Why?
|
Hospitals, General | 2 | 2017 | 712 | 0.050 |
Why?
|
Equipment Design | 2 | 2003 | 3627 | 0.050 |
Why?
|
Respiratory Function Tests | 3 | 2010 | 1673 | 0.050 |
Why?
|
Larynx | 1 | 2004 | 466 | 0.050 |
Why?
|
Pneumonia | 1 | 2012 | 2080 | 0.050 |
Why?
|
Papillomaviridae | 2 | 1999 | 1124 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11253 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 39292 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 1028 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12447 | 0.050 |
Why?
|
Palliative Care | 2 | 2006 | 3261 | 0.050 |
Why?
|
Leiomyoma | 1 | 2005 | 685 | 0.050 |
Why?
|
Papain | 1 | 1999 | 64 | 0.050 |
Why?
|
Perioperative Period | 1 | 2021 | 262 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2016 | 7026 | 0.050 |
Why?
|
Chymotrypsin | 1 | 1999 | 166 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2003 | 329 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4297 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 13274 | 0.050 |
Why?
|
Odds Ratio | 2 | 2009 | 9754 | 0.050 |
Why?
|
Annual Reports as Topic | 1 | 2018 | 36 | 0.050 |
Why?
|
Cocarcinogenesis | 3 | 1987 | 43 | 0.050 |
Why?
|
Preoperative Period | 1 | 2021 | 552 | 0.050 |
Why?
|
Mentors | 1 | 2004 | 604 | 0.040 |
Why?
|
Digestive System Neoplasms | 1 | 1999 | 83 | 0.040 |
Why?
|
Education, Medical, Continuing | 2 | 2017 | 868 | 0.040 |
Why?
|
Shoulder Dislocation | 1 | 1999 | 108 | 0.040 |
Why?
|
Shoulder Fractures | 1 | 1999 | 79 | 0.040 |
Why?
|
Liposarcoma | 1 | 2001 | 308 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2003 | 524 | 0.040 |
Why?
|
Surgical Procedures, Operative | 2 | 2004 | 1880 | 0.040 |
Why?
|
Carcinogens | 3 | 1989 | 393 | 0.040 |
Why?
|
Logistic Models | 2 | 2021 | 13468 | 0.040 |
Why?
|
Humerus | 1 | 1999 | 251 | 0.040 |
Why?
|
Hair Follicle | 1 | 1999 | 220 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2003 | 882 | 0.040 |
Why?
|
Epidermal Growth Factor | 3 | 1998 | 724 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 1999 | 227 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 380 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2587 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12863 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 384 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 34151 | 0.040 |
Why?
|
Thorax | 1 | 1999 | 512 | 0.040 |
Why?
|
Anorexia | 1 | 2016 | 157 | 0.040 |
Why?
|
Total Lung Capacity | 1 | 1996 | 152 | 0.040 |
Why?
|
Radiotherapy | 1 | 2003 | 1623 | 0.040 |
Why?
|
Manometry | 1 | 2017 | 419 | 0.040 |
Why?
|
Paclitaxel | 2 | 2001 | 1655 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2018 | 572 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 630 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 3014 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 668 | 0.030 |
Why?
|
Cisplatin | 2 | 2016 | 1651 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2149 | 0.030 |
Why?
|
Young Adult | 7 | 2019 | 55940 | 0.030 |
Why?
|
Models, Economic | 1 | 2018 | 723 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2307 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4293 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 654 | 0.030 |
Why?
|
Camptothecin | 1 | 2016 | 555 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 925 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2003 | 1852 | 0.030 |
Why?
|
Dimethylhydrazines | 2 | 1989 | 12 | 0.030 |
Why?
|
Dilatation | 1 | 1993 | 264 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 875 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12292 | 0.030 |
Why?
|
Cardia | 1 | 2011 | 55 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1996 | 1139 | 0.030 |
Why?
|
Equipment Failure | 1 | 1994 | 586 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1993 | 472 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 685 | 0.020 |
Why?
|
Methylhydrazines | 1 | 1989 | 6 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 987 | 0.020 |
Why?
|
Pain | 1 | 2005 | 4636 | 0.020 |
Why?
|
Nitrosamines | 2 | 1987 | 81 | 0.020 |
Why?
|
Colitis | 2 | 1989 | 1140 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 580 | 0.020 |
Why?
|
Transsexualism | 1 | 2012 | 152 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1325 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15252 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2008 | 111 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3944 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18712 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 65 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11323 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1822 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 5045 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3290 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 2987 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 910 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1988 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1378 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 916 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 2008 | 413 | 0.020 |
Why?
|
Spirometry | 1 | 2009 | 866 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 626 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6530 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3436 | 0.020 |
Why?
|
Chylothorax | 1 | 2006 | 90 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 6068 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 15538 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5235 | 0.020 |
Why?
|
Polypropylenes | 1 | 2005 | 58 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2945 | 0.020 |
Why?
|
Colonic Neoplasms | 2 | 1989 | 2535 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 791 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 202 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1060 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2004 | 92 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3562 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1346 | 0.020 |
Why?
|
Infant | 2 | 2019 | 34261 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 298 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3518 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2011 | 964 | 0.020 |
Why?
|
Netherlands | 1 | 2008 | 2068 | 0.020 |
Why?
|
Oxygen | 1 | 1996 | 4150 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1993 | 2125 | 0.020 |
Why?
|
Sex Factors | 2 | 2008 | 10566 | 0.020 |
Why?
|
Perioperative Care | 1 | 2012 | 1067 | 0.020 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 4930 | 0.010 |
Why?
|
Laminectomy | 1 | 2003 | 236 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2008 | 792 | 0.010 |
Why?
|
Genes, Reporter | 2 | 1999 | 1611 | 0.010 |
Why?
|
Smoking | 2 | 2010 | 8612 | 0.010 |
Why?
|
Graft Survival | 1 | 1992 | 3767 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 1154 | 0.010 |
Why?
|
Vitamin E | 1 | 1986 | 842 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6293 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1131 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 1999 | 9927 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1987 | 768 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 276 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 611 | 0.010 |
Why?
|
Transfection | 2 | 1999 | 6161 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1312 | 0.010 |
Why?
|
Iontophoresis | 1 | 1999 | 76 | 0.010 |
Why?
|
Autopsy | 1 | 2003 | 990 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3070 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2878 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6451 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2003 | 901 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 673 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 167 | 0.010 |
Why?
|
1,2-Dimethylhydrazine | 2 | 1989 | 8 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9402 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1998 | 139 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 674 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 1005 | 0.010 |
Why?
|
Receptor, erbB-3 | 1 | 1998 | 125 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 1999 | 332 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 4883 | 0.010 |
Why?
|
Mesocricetus | 2 | 1987 | 286 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1725 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 1632 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 416 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1996 | 125 | 0.010 |
Why?
|
Neutropenia | 1 | 2001 | 871 | 0.010 |
Why?
|
Liposomes | 1 | 1999 | 754 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 1026 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3495 | 0.010 |
Why?
|
Actins | 1 | 2003 | 2191 | 0.010 |
Why?
|
Mitosis | 1 | 2001 | 1250 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 8014 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1987 | 2029 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13298 | 0.010 |
Why?
|
Graft Rejection | 1 | 2008 | 4408 | 0.010 |
Why?
|
Drug Carriers | 1 | 1999 | 715 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6757 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3354 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10339 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2673 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2800 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5034 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 915 | 0.010 |
Why?
|
Animals | 9 | 2003 | 170486 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1993 | 295 | 0.010 |
Why?
|
Cricetinae | 2 | 1987 | 2588 | 0.010 |
Why?
|
Mice | 6 | 1999 | 80876 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 2020 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 1993 | 308 | 0.010 |
Why?
|
Dexamethasone | 1 | 1999 | 1939 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 5041 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 3021 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3297 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13647 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 1998 | 2307 | 0.010 |
Why?
|
FANFT | 1 | 1987 | 1 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1998 | 3563 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6850 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1993 | 2877 | 0.010 |
Why?
|
Cystitis | 1 | 1987 | 86 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 29262 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1999 | 3690 | 0.000 |
Why?
|
Rats | 1 | 2003 | 25094 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8720 | 0.000 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1986 | 177 | 0.000 |
Why?
|
Free Radicals | 1 | 1986 | 257 | 0.000 |
Why?
|
Acetylcysteine | 1 | 1987 | 287 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 11239 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4677 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18375 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 16657 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 1922 | 0.000 |
Why?
|
Base Sequence | 1 | 1993 | 13352 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1999 | 22989 | 0.000 |
Why?
|
Oncogenes | 1 | 1986 | 1244 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 18748 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4325 | 0.000 |
Why?
|
Cell Division | 1 | 1986 | 4752 | 0.000 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 2913 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4680 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 11594 | 0.000 |
Why?
|
Diet | 1 | 1986 | 7392 | 0.000 |
Why?
|